XFOR
#3050
X4 Pharmaceuticals, Inc. - Common Stock
4.2 3 USD
+0.01%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+1.44%
Monthly Change
+7.63%
6 month change
+27.60%
Year Change
+42.42%
Previous Close
4.1 7
Open
4.2 3
Low
4.2 3
High
4.2 3
Volume
31
Financials
- Market Capitalization 419.39 M
- Employee 45
- Founded 2019
- CEO N/A
- Website www.x4pharma.com
- Headquarter Delaware, United States
- FIGI BBG001J1CYH8
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-2.14
Price to sales ratio
26.03
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3023 |  BNTC Benitec Biopharma Inc. - Common Stock | 12.67 USD | -1.63% | -3.58% | +5.50% | -23.72% | 435.27 M USD | ||
| 3048 |  LRMR Larimar Therapeutics, Inc. - Common Stock | 4.05 USD | -2.88% | -3.80% | +6.30% | +3.32% | 420.73 M USD | ||
| 3052 |  GALT Galectin Therapeutics Inc. - Common Stock | 4.14 USD | -0.24% | +14.36% | +20.70% | -1.43% | 417.52 M USD | ||
| 3062 |  FENC Fennec Pharmaceuticals Inc. - Common Stock | 11.77 USD | -3.29% | +2.62% | +17.00% | +31.36% | 412.74 M USD |
Frequently asked questions about X4 Pharmaceuticals, Inc. Common Stock
What is the X4 Pharmaceuticals, Inc. Common Stock stock price today?
The current price of X4 Pharmaceuticals, Inc. Common Stock (XFOR) is 4.23. Over the past 24 hours, the stock has changed by +1.44%. Follow the XFOR chart for real-time price dynamics.
What is the stock ticker of X4 Pharmaceuticals, Inc. Common Stock?
X4 Pharmaceuticals, Inc. Common Stock trades under the ticker XFOR. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is X4 Pharmaceuticals, Inc. Common Stock stock going up?
XFOR has changed by +4.44% over the last week, +7.63% over the last month, and +42.42% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of X4 Pharmaceuticals, Inc. Common Stock?
X4 Pharmaceuticals, Inc. Common Stock currently has a market capitalization of 419.39 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were X4 Pharmaceuticals, Inc. Common Stock earnings last quarter?
Last quarter, X4 Pharmaceuticals, Inc. Common Stock reported earnings of -0.13 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was X4 Pharmaceuticals, Inc. Common Stock revenue for the last quarter?
X4 Pharmaceuticals, Inc. Common Stock reported quarterly revenue of 2.4 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was X4 Pharmaceuticals, Inc. Common Stock net income for the last quarter?
X4 Pharmaceuticals, Inc. Common Stock reported net income of -16.16 M for the last quarter. The previous quarter showed -20.24 M, which means net income changed by +20.18%.
How many employees does X4 Pharmaceuticals, Inc. Common Stock have?
As of the latest available data, X4 Pharmaceuticals, Inc. Common Stock has 45 employees. Workforce size can provide additional context about the company's scale and operations.
What is X4 Pharmaceuticals, Inc. Common Stock EBITDA?
X4 Pharmaceuticals, Inc. Common Stock EBITDA is -6.96 M, and its EBITDA margin is -289.83%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy X4 Pharmaceuticals, Inc. Common Stock stock?
You can buy X4 Pharmaceuticals, Inc. Common Stock (XFOR) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in X4 Pharmaceuticals, Inc. Common Stock stock?
Investing in X4 Pharmaceuticals, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the XFOR chart and related analysis on metatrader.com as part of your research.